Related Experiment Video
Updated: Sep 8, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.2K
A Novel Key Features Screening Method Based on Extreme Learning Machine for Alzheimer's Disease Study.
Jia Lu1, Weiming Zeng1, Lu Zhang2
1Laboratory of Digital Image and Intelligent Computation, Shanghai Maritime University, Shanghai, China.
Frontiers in Aging Neuroscience
|June 13, 2022
Summary
A new method, Key Features Screening Method based on Extreme Learning Machine (KFS-ELM), effectively identifies crucial features for Alzheimer's disease (AD) diagnosis. This approach significantly improves diagnostic accuracy by focusing on the most impactful data points.
Area of Science:
- Computational Neuroscience
- Machine Learning in Medicine
- Biomedical Data Analysis
Background:
- Extreme Learning Machine (ELM) is an efficient algorithm for Single Hidden Layer Feedforward Neural Networks (SLFNs).
- ELM has been increasingly applied to Alzheimer's disease (AD) research, particularly for diagnosing AD using high-dimensional data.
- High-dimensional datasets often contain irrelevant or redundant features that can hinder diagnostic accuracy.
Purpose of the Study:
- To propose a novel Key Features Screening Method based on Extreme Learning Machine (KFS-ELM).
- To screen for and assign importance weights to key features relevant for Alzheimer's disease classification.
- To evaluate the effectiveness of KFS-ELM in improving AD diagnostic accuracy and understanding feature relevance.
Main Methods:
- Developed and applied the Key Features Screening Method based on Extreme Learning Machine (KFS-ELM).
- Experimentally screened 920 key functional connections from an initial set of 4005 functional connections for AD diagnosis.
- Assigned weights to the identified key features based on their contribution to classification.
Main Results:
- Diagnostic accuracy increased from 95.33% using all 4005 features to 99.20% using only the 920 key features identified by KFS-ELM.
- The 3085 features screened out negatively impacted AD diagnosis, confirming the effectiveness of KFS-ELM in feature selection.
- The KFS-ELM demonstrated a rational weighting system, where higher weights correlated with greater impact on AD diagnosis.
Conclusions:
- KFS-ELM is an effective method for screening key features and improving classification accuracy in Alzheimer's disease diagnosis.
- The method provides valuable insights into feature importance, aiding in the study of AD.
- KFS-ELM offers a robust tool for both feature analysis and enhancing diagnostic performance in complex medical datasets.
Related Concept Videos
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666

